Substance Abuse-Related Self-Stigma in Women with Substance Use Disorder and Comorbid Posttraumatic Stress Disorder.


Journal

European addiction research
ISSN: 1421-9891
Titre abrégé: Eur Addict Res
Pays: Switzerland
ID NLM: 9502920

Informations de publication

Date de publication:
2019
Historique:
received: 06 08 2018
accepted: 05 12 2018
pubmed: 10 1 2019
medline: 24 4 2019
entrez: 10 1 2019
Statut: ppublish

Résumé

Self-stigma is a result of internalizing negative stereotypes by the affected person. Research on self-stigma in substance use disorders (SUD) is still scarce, especially regarding the role of childhood trauma and subsequent posttraumatic disorders. The present study investigated the progressive model of self-stigma in women with SUD and posttraumatic stress disorder (PTSD), and the predictive value of PTSD severity and childhood trauma experiences on self-stigma. In a cross-sectional study with 343 women with SUD and PTSD, we used the Self-Stigma in Alcohol Dependency Scale, the Childhood Trauma Questionnaire (CTQ), the PTSD Symptom Scale Interview (PSS-I), and to control for SUD severity and depression, the Addiction Severity Index Lite and the Beck Depression Inventory-II. Hierarchical regression analyses were conducted for each stage of self-stigma (aware-agree-apply-harm). The interrelated successive stages of self-stigma were largely confirmed. In the regression models, no significant effects of the PSS-I- and the CTQ-scores were observed at any stage of self-stigma. Agreeing with negative stereotypes was solely predicted by younger age, applying these stereotypes to oneself was higher in women with younger age, higher depression and SUD severity, and suffering from the application (harm) was only predicted by depression. The progressive model of self-stigma could be confirmed in women with SUD and PTSD, but PTSD severity and childhood trauma did not directly affect this process. Self-stigma appears to be related to depression in a stronger way than PTSD is related to women with SUD and PTSD.

Sections du résumé

BACKGROUND BACKGROUND
Self-stigma is a result of internalizing negative stereotypes by the affected person. Research on self-stigma in substance use disorders (SUD) is still scarce, especially regarding the role of childhood trauma and subsequent posttraumatic disorders.
OBJECTIVES OBJECTIVE
The present study investigated the progressive model of self-stigma in women with SUD and posttraumatic stress disorder (PTSD), and the predictive value of PTSD severity and childhood trauma experiences on self-stigma.
METHOD METHODS
In a cross-sectional study with 343 women with SUD and PTSD, we used the Self-Stigma in Alcohol Dependency Scale, the Childhood Trauma Questionnaire (CTQ), the PTSD Symptom Scale Interview (PSS-I), and to control for SUD severity and depression, the Addiction Severity Index Lite and the Beck Depression Inventory-II. Hierarchical regression analyses were conducted for each stage of self-stigma (aware-agree-apply-harm).
RESULTS RESULTS
The interrelated successive stages of self-stigma were largely confirmed. In the regression models, no significant effects of the PSS-I- and the CTQ-scores were observed at any stage of self-stigma. Agreeing with negative stereotypes was solely predicted by younger age, applying these stereotypes to oneself was higher in women with younger age, higher depression and SUD severity, and suffering from the application (harm) was only predicted by depression.
CONCLUSIONS CONCLUSIONS
The progressive model of self-stigma could be confirmed in women with SUD and PTSD, but PTSD severity and childhood trauma did not directly affect this process. Self-stigma appears to be related to depression in a stronger way than PTSD is related to women with SUD and PTSD.

Identifiants

pubmed: 30625465
pii: 000496113
doi: 10.1159/000496113
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-29

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Hanne Melchior (H)

Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, hmelchior@uke.de.
Center for Interdisciplinary Addiction Research, University of Hamburg, Hamburg, Germany, hmelchior@uke.de.

Paul Hüsing (P)

Center for Interdisciplinary Addiction Research, University of Hamburg, Hamburg, Germany.
Department of Psychiatry and Psychotherapy, Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Johanna Grundmann (J)

Center for Interdisciplinary Addiction Research, University of Hamburg, Hamburg, Germany.
Department of Psychiatry and Psychotherapy, Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Annett Lotzin (A)

Center for Interdisciplinary Addiction Research, University of Hamburg, Hamburg, Germany.
Department of Psychiatry and Psychotherapy, Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Philipp Hiller (P)

Center for Interdisciplinary Addiction Research, University of Hamburg, Hamburg, Germany.
Department of Psychiatry and Psychotherapy, Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Yiqi Pan (Y)

Center for Interdisciplinary Addiction Research, University of Hamburg, Hamburg, Germany.
Department of Psychiatry and Psychotherapy, Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Martin Driessen (M)

Clinic of Psychiatry and Psychotherapy, Bethel Hospital and University of Bielefeld, Bielefeld, Germany.

Norbert Scherbaum (N)

LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Duisburg-Essen, Essen, Germany.

Barbara Schneider (B)

Department of Psychiatry and Addictive Disorders, LVR-Hospital Cologne, Cologne, Germany.
Department of Psychiatry and Psychotherapy, Goethe-University Frankfurt, Frankfurt, Germany.

Thomas Hillemacher (T)

Department of Psychiatry, Socialpsychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany.
Department of Psychiatry and Psychotherapy, Paracelsus Medical University, Nuremberg, Germany.

Susanne Stolzenburg (S)

Department of Psychiatry, Greifswald University, Greifswald, Germany.

Georg Schomerus (G)

Department of Psychiatry, Greifswald University, Greifswald, Germany.

Ingo Schäfer (I)

Center for Interdisciplinary Addiction Research, University of Hamburg, Hamburg, Germany.
Department of Psychiatry and Psychotherapy, Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH